Condition
IDH Wildtype Glioblastoma clinical trials and research
Research outlook What's coming for Glioblastoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 IDH Wildtype Glioblastoma clinical trials that are recruiting, at sites in 2 countries (most in Italy (1), Canada (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Metabolomics and Transcriptomics of Gliomas
Researchers are testing whether metabolic and gene-expression profiles can reveal new glioma subgroups and improve models to study and develop treatments for IDH wildtype glioblastoma and IDH-mutant lower-grade gliomas.
-
Timing of Temozolomide for Glioblastoma Treatment
This study is testing whether taking the cancer drug temozolomide in the morning or evening helps people with glioblastoma feel better and have fewer side effects.
Related topics
Quick answers
How many IDH Wildtype Glioblastoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.